Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detectedMarc Suárez‐Calvet, Natàlia Vilor‐Tejedor, Gwendlyn Kollmorgen et al.|EMBO Molecular Medicine|2020Cited by 411
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's <i>continuum</i>Marta Milà‐Alomà, Gemma Salvadó, Juan Domingo Gispert et al.|Alzheimer s & Dementia|2020Cited by 260
Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkersJuan Domingo Gispert, Gemma Salvadó, José Luís Molinuevo et al.|Alzheimer s Research & Therapy|2019Cited by 201
Dementia prevention in memory clinics: recommendations from the European task force for brain health servicesGiovanni B. Frisoni, Bruno Dubois, Daniele Altomare et al.|The Lancet Regional Health - Europe|2023Cited by 181
Association between insomnia and cognitive performance, gray matter volume, and white matter microstructure in cognitively unimpaired adultsJosé Luís Molinuevo, Oriol Grau‐Rivera, Grégory Operto et al.|Alzheimer s Research & Therapy|2020Cited by 113